About US
Atavistic chemotherapy is an entirely different new generation of oral chemotherapy for cancer.
Unlike traditional chemotherapy methods, this approach is non-toxic, reducing the need for hospitalization and thus presenting a more convenient treatment option for patients.
Its effectiveness has been established in a wide range of inoperable and metastatic cancers. This offers significant promise even if it does not guarantee a cure in every case. Importantly, all drugs utilized within this regimen are FDA-approved and have been a part of medical practice for decades, albeit for treating other diseases.
This innovative method’s credibility is further bolstered by its inclusion in the United States clinical trials registry since 2015. This was under the identifier ClinicalTrials.gov NCT02366884. This shows its recognition and the ongoing research into its potential benefits in cancer treatment.
We accept the enrolment of patients with inoperable or metastatic cancers in which we believe, based on our experience, that the complete eradication of the disease is likely with atavistic chemotherapy. Also, patients wanting to avoid disfiguring or incapacitating radical surgery are encouraged to contact us. Objective results are guaranteed to be observed in the first two weeks of initiated treatment.
Atavistic Chemotherapy: Your Success is Our Goal
We are immensely proud of having developed and optimized this new and revolutionary treatment. Our confidence in atavistic chemotherapy is such that if we accept you in our treatment program, we guarantee a complete regression of your cancer.
Your survival is our goal and part of our efforts to document that atavistic chemotherapy is the correct scientific approach to understand and treat cancer humanely and effectively.
It may not be a lucrative approach for the pharmaceutical industry or those who made their livelihood from the old traditional oncology, but it is a lifesaving approach for those with inoperable and metastatic cancer. If you have been diagnosed with cancer, contact us!